Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
Ahmed, M Dorling, L Kerns, S Fachal, L Elliott, Rebecca M Parliament, M Rosenstein, B Vega, A Gómez-Caamaño, A Barnett, G
Ahmed, M
Dorling, L
Kerns, S
Fachal, L
Elliott, Rebecca M
Parliament, M
Rosenstein, B
Vega, A
Gómez-Caamaño, A
Barnett, G
Citations
Altmetric:
Abstract
Numerous germline single-nucleotide polymorphisms increase susceptibility to prostate cancer, some lying near genes involved in cellular radiation response. This study investigated whether prostate cancer patients with a high genetic risk have increased toxicity following radiotherapy.
Description
Date
2016-05-10
Publisher
Collections
Keywords
Type
Article
Citation
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. 2016, 114 (10):1165-74 Br J Cancer